Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

Recruiting now

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.

Key facts

Study ID

NCT06960798

Run by

University of Oklahoma

People needed

150

Starts

2026-05-02

Expected to finish

2029-06-30

Last updated by the study team

2026-03-02

Who can join

Age: 18 and older, up to 100. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Written informed consent signed and dated by the patient prior to the performance of any study-specific procedures, sampling, or analyses.
• At least 18 years-of-age at the time of signature of the informed consent form (ICF).
• Patients who self-identify as Native American.
• Patients with a pathologically proven diagnosis of PC (any stage).
• Availability of most recent archived tumor samples.

You may not qualify if…

• Patients not of Native American descent or identity.
• Patient does not have archival tissue available.

Where it is running

• OU Health Stephenson Cancer Center — Oklahoma City, Oklahoma, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.